Medicines and Healthcare Products

Open letter to the global pharmaceutical and biopharmaceutical industry

by Chris Martin
Medicines and Healthcare Products

Open letter to the global pharmaceutical and biopharmaceutical industry, We are writing on behalf of the UK Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator of medicines, medical… Read More »Open letter to the global pharmaceutical and biopharmaceutical industry

First major overhaul of medical device regulation comes into force across Great Britain.

by Chris Martin
Medicines and Healthcare Products

New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.